Public Calendar: June 24 - 30, 2018
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date: 06/25/2018
Location: Washington, DC
Subject: National Comprehensive Cancer Network Policy Summit: Policy Strategies for the "New Normal" in Healthcare to Ensure Access to High Quality Cancer Care
FDA Participant/Group: Devlin, Nina P;
Non FDA Participant/Group: Media, industry, government, and other invited participants
Event Date: 06/27/2018
Location: Silver Spring, MD
Subject: Opioid Summit with Social Media Companies
FDA Participant/Group: Several senior leaders and staff from the FDA
Non FDA Participant/Group: Industry, academia, government and other invited participants
Official Name: Rachel Sherman, M.D., M.P.H., Principal Deputy Commissioner
Event Date: 06/26/2018
Location: Cambridge, MA
Subject: Boston Chief Medical Officers Network 2018 Presentation
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Chief Medical Officers Network
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 06/28/2018
Location: Boston, MA
Subject: Drug Information Association 2018 Global Annual Meeting
FDA Participant/Group: Marks, Peter W;
Non FDA Participant/Group: N/A
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 06/27/2018
Location: Washington, DC
Subject: Medical Device Innovation Consortium: Case for Quality Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date: 06/24/2018
Location: Clearwater, FL
Subject: Teratology Society 2018 Annual Meeting: Mechanisms, Models, Mothers and Babies: Bringing Birth Defects Research into Practice
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A
Official Name: Rebecca K. Wood, J.D., Chief Counsel
No Significant Event